Vaccine and Antibody Treatment of Prostate Cancer

NCT00113984 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Prostatic Neoplasms

Interventions

BIOLOGICAL: PROSTVAC-V/TRICOM
BIOLOGICAL: PROSTVAC-F/TRICOM
DRUG: MDX-010
DRUG: Sargramostim

Sponsor

National Cancer Institute (NCI)